In case you missed it: August 8 to August 12
A look back at the week's top stories.
Vivjoa approved for recurrent vulvovaginal candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
Essentials of vulvovaginal dermatology
Correct terms and education can help normalize the conversation for patients.
Neighborhood disadvantage and fertility rates
Residing in a socioeconomically disadvantaged neighborhood was linked to moderately decreased fecundability, according to a study published in JAMA Network Open.
Maternal mortality before and during COVID pandemic
Maternal deaths in the United States rose by a staggering 33% after the onset of the COVID-19 pandemic in March 2020, which is a significantly higher percentage than the 22% overall excess death estimate linked to the pandemic, according to a research letter published in JAMA Network Open.
Monkeypox vaccine gets emergency approval to increase vaccine supply
Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
